Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents
Research output: Contribution to journal › Letter › Research › peer-review
Documents
- Fulltext
Final published version, 259 KB, PDF document
In this prospective nationwide multicenter study from Denmark, myopericarditis after Pfizer-BioNTech mRNA COVID-19 vaccination was identified in 13 males and 2 females between May 15 and September 15, 2021, among 133,477 vaccinated males and 127,857 vaccinated females 12-17 years of age, equaling 97 males and 16 females per million. In conclusion, the incidence of myopericarditis after COVID-19 vaccination among males appears higher than reports from the United States.
Original language | English |
---|---|
Journal | Pediatric Infectious Disease Journal |
Volume | 41 |
Issue number | 1 |
Pages (from-to) | E25-E28 |
Number of pages | 4 |
ISSN | 0891-3668 |
DOIs | |
Publication status | Published - Jan 2022 |
- mRNA COVID-19 vaccine, myopericarditis, adolescents Accepted for publication October 10, 2021
Research areas
ID: 315536037